Europe Non-Alcoholic Steatopatitis Market Segmentation,
Application, Trends 2028

According to a new market research study on the Europe
Non-Alcoholic Steatohepatitis Market Forecast to 2028 –– by product,
application, sales channel and countries is expected to reach US$ 12,963.42
million by 2028 from US$ 838.07 million in 2021. The market is estimated to
grow at a CAGR of 47.9% from 2021 to 2028. The report provides trends
prevailing in the Europe Non-Alcoholic Steatohepatitis market along with the
drivers and restraints pertaining to the market growth. Rising prevalence of
NASH is the major factor driving the growth of the market. However, issues
associated with stringent regulations related to Non-Alcoholic Steatohepatitis
the growth of Europe Non-Alcoholic Steatohepatitis market.

Non-Alcoholic Steatohepatitis (NASH) Awareness and Market
Growth

Europe Non-Alcoholic Steatohepatitis Market is an
under-recognized condition requiring increased public and primary care
physician (PCP) awareness for early detection and effective management.
Establishing clear referral pathways and public awareness campaigns are crucial
for identifying and referring patients to specialists.

Efforts to raise NASH awareness include:

• International
  NASH Day (June 12th):




• The
  NASH Education Program launched a public campaign in 2018 to highlight
  NASH, affecting approximately 115 million people.


• In
  2019, NASH 24X7, a digital platform, implemented programs for healthcare
  professional (HCP) support, patient awareness, and media outreach.


• NASH
  Crusaders collaborated with HCPs in India to conduct workshops on liver
  health and lifestyle changes to prevent NAFLD/NASH.


• Digital
  and print media were used for press releases and television programs.

Europe Non-Alcoholic Steatohepatitis Market Analysis

The Europe Non-Alcoholic Steatohepatitis Market is projected
to experience significant growth. Key market segmentations include:

• Product:




• Segments
  include vitamin E and pioglitazone, ocaliva, elafibranor, selonsertib
  & cenicriviroc, and others.


• The
  selonsertib & cenicriviroc segment is expected to exhibit the fastest
  growth.




• Application:




• Divided
  into treatment and diagnosis, with treatment dominating the market in
  2020.




• Sales
  Channel:




• Includes
  hospital pharmacies, online providers, and retail pharmacies, with retail
  pharmacies holding the largest market share in 2020.




• Country:




• Germany,
  the UK, France, Italy, Spain, and the rest of Europe.


• Germany
  held the largest market share in 2020.

Key Market Players:

Leading companies in the Europe Non-Alcoholic
Steatohepatitis Market include:

• Cadila
  Pharmaceutical


• Intercept
  Pharmaceutical


• Novartis
  AG


• Galmed
  Pharmaceutical


• GENFIT


• ONE
  WAY LIVER SI


• BioPredictive
  S.A.S


• Siemens
  Healthineers AG


• Laboratory
  Corporation of America Holdings

Other Report:

Europe Smart Kitchen Appliance Market: https://penzu.com/p/cb91cd986d5b8400 

Europe Plasma Fractionation Market: https://business-news-insights.blogspot.com/2025/04/europe-plasma-fractionation-market.html 

Europe Bathroom Vanities Market: https://sites.google.com/view/europe-bathroom-vanities-marke/home 

Europe Vanilla Market: https://www.quora.com/profile/Business-Market-Insights/Europe-Vanilla-Market-SWOT-Analysis-Segmentations-Development-2028

About Us:

Business Market Insights is a market research platform
that provides subscription service for industry and company reports. Our
research team has extensive professional expertise in domains such as
Electronics & Semiconductor; Aerospace & Defense; Automotive &
Transportation; Energy & Power; Healthcare; Manufacturing &
Construction; Food & Beverages; Chemicals & Materials; and Technology,
Media, & Telecommunications.

Author’s Bio:

Suryakant Gadekar

Senior Market Research Expert at Business Market
Insights